Effect of low dose 1 alpha-hydroxycholecalciferol on glomerular filtration rate in moderate renal failure.
Open Access
- 1 October 1983
- journal article
- research article
- Published by BMJ in Archives of Disease in Childhood
- Vol. 58 (10) , 810-813
- https://doi.org/10.1136/adc.58.10.810
Abstract
Serial measurements of 51Cr edetic acid clearance were made over a period of one year in two groups of 8 children, in a double blind trial of 1 alpha-hydroxycholecalciferol (10 ng/kg/day) and calciferol (670 ng/kg/day). Glomerular filtration rate (GFR) at the beginning of the trial was 20-50 ml/min/1.73 m2; it rose in the children given 1 alpha-hydroxycholecalciferol (group A) after 6 months but was not appreciably different from the pretreatment value after 12 months. The GFR in the children given calciferol (group B) showed no significant difference at 6 or 12 months. Parathyroid hormone values fell markedly in group A after 6 months but not in group B. Quantitative bone histology improved considerably in group A but not in group B at 12 months. Low dose 1 alpha-hydroxycholecalciferol may be used effectively for renal osteodystrophy in children with moderate but stable renal failure without jeopardising renal function.This publication has 20 references indexed in Scilit:
- Effects of Vitamin D Metabolites and Analogues on Renal FunctionNephron, 1981
- PROPRANOLOL IN URÆMIC OSTEODYSTROPHYThe Lancet, 1978
- VITAMIN-D ANALOGUES AND RENAL FUNCTIONThe Lancet, 1978
- IMPAIRMENT OF RENAL FUNCTION IN PATIENTS ON 1α-HYDROXYCHOLECALCIFEROLThe Lancet, 1978
- A POSSIBLE ROLE FOR PROPRANOLOL IN THE TREATMENT OF RENAL OSTEODYSTROPHYThe Lancet, 1978
- IMPAIRMENT OF RENAL FUNCTION IN PATIENTS ON 1$alpha;-HYDROXYCHOLECALCIFEROLThe Lancet, 1978
- Renal osteodystrophy in nondialysed adolescents. Long-term treatment with 1alpha-hydroxycholecalciferol.Archives of Disease in Childhood, 1977
- 1α-Hydroxycholecalciferol in renal osteodystrophyCalcified Tissue International, 1976
- Comparison of effects of 1 alpha-hydroxy-vitamin D3 and 1,25-dihydroxy-vitamin D3 in man.Journal of Clinical Investigation, 1976
- CONTROLLED TRIAL OF 1α-HYDROXYCHOLECALCIFEROL IN CHRONIC RENAL FAILUREThe Lancet, 1976